- Home
- KVUE vs LVS Comparison
KVUE vs LVS Comparison
Compare KVUE & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVUE
- LVS
- Stock Information
- Founded
- KVUE 2022
- LVS 1988
- Country
- KVUE United States
- LVS United States
- Employees
- KVUE N/A
- LVS N/A
- Industry
- KVUE Specialty Chemicals
- LVS Hotels/Resorts
- Sector
- KVUE Consumer Discretionary
- LVS Consumer Discretionary
- Exchange
- KVUE Nasdaq
- LVS Nasdaq
- Market Cap
- KVUE 41.0B
- LVS 34.2B
- IPO Year
- KVUE 2023
- LVS 2004
- Fundamental
- Price
- KVUE $21.83
- LVS $50.23
- Analyst Decision
- KVUE Buy
- LVS Buy
- Analyst Count
- KVUE 12
- LVS 14
- Target Price
- KVUE $25.33
- LVS $55.62
- AVG Volume (30 Days)
- KVUE 19.7M
- LVS 4.7M
- Earning Date
- KVUE 08-05-2025
- LVS 07-23-2025
- Dividend Yield
- KVUE 3.75%
- LVS 1.99%
- EPS Growth
- KVUE N/A
- LVS N/A
- EPS
- KVUE 0.55
- LVS 1.78
- Revenue
- KVUE $15,302,000,000.00
- LVS $11,201,000,000.00
- Revenue This Year
- KVUE $2.94
- LVS $5.22
- Revenue Next Year
- KVUE $3.51
- LVS $5.86
- P/E Ratio
- KVUE $39.59
- LVS $28.15
- Revenue Growth
- KVUE N/A
- LVS N/A
- 52 Week Low
- KVUE $17.85
- LVS $30.18
- 52 Week High
- KVUE $25.17
- LVS $56.61
- Technical
- Relative Strength Index (RSI)
- KVUE 55.67
- LVS 75.08
- Support Level
- KVUE $20.65
- LVS $47.47
- Resistance Level
- KVUE $21.15
- LVS $50.67
- Average True Range (ATR)
- KVUE 0.47
- LVS 1.01
- MACD
- KVUE 0.14
- LVS 0.47
- Stochastic Oscillator
- KVUE 64.13
- LVS 94.89
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.